Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Net Income | 86.79% | 86.40% | 85.35% | -946.55% | -2,984.87% |
| Total Depreciation and Amortization | -99.93% | -99.95% | -97.93% | -53.15% | 98.76% |
| Total Amortization of Deferred Charges | 892.38% | 4,118.52% | -- | -- | -- |
| Total Other Non-Cash Items | -89.63% | -88.76% | -88.72% | 28,201.01% | 3,730.24% |
| Change in Net Operating Assets | 11.16% | 1,525.63% | 394.27% | 205.90% | 225.55% |
| Cash from Operations | 66.91% | 80.60% | 80.17% | 60.14% | 22.57% |
| Capital Expenditure | -- | -- | -- | -41.60% | -41.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | 200.00% |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | 115.42% | 114.44% | -- | 242.40% | -189.16% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.17% | 1,041.00% | -87.16% | -87.62% | -92.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.37% | 99.81% | -661.58% | -192.48% | -197.88% |